Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01666145 · ClinicalTrials.gov registry record · NA

Advanced Image Guidance Utilized in Liver Surgery

A NA study of Carcinoma, Hepatocellular, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT01666145: Completed NA study of Carcinoma, Hepatocellular, sponsored by Wake Forest University Health Sciences.

NCT01666145 is a NA study of Carcinoma, Hepatocellular that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 14 participants, below the 612-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01666145, a NA study of Carcinoma, Hepatocellular, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Advanced Image Guidance for this study was used during laparoscopic microwave ablation surgery to help the surgeon accurately place the ablation needle into the tumor of patients diagnosed with liver cancer.

Primary Outcome

Once the ablation antenna has been placed into the target lesion, the success or failure of the attempt will be confirmed with conventional ultrasound alone, in two planes. If the placement is deemed successful, the surgeon will commence the ablation of the tumor. If the placement is deemed insufficient, the probe will be removed and another placement will be attempted using conventional guidance.

Conditions Studied

Interventions

  • DEVICE Advanced Image Guidance

Study Locations (1)

North Carolina

  • Carolinas Health System - Charlotte

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2012-02
Est. Completion 2014-02
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01666145 record still lists

NCT01666145 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 612-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 1 intervention - of which Advanced Image Guidance is the first listed.

NCT01666145 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01666145 about?

NCT01666145 is a clinical study titled "Advanced Image Guidance Utilized in Liver Surgery". Advanced Image Guidance for this study was used during laparoscopic microwave ablation surgery to help the surgeon accurately place the ablation needle into the tumor of patients diagnosed with liver cancer.

What is the current status of trial NCT01666145?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2012-02. Estimated completion is 2014-02.

What conditions does trial NCT01666145 study?

This clinical trial studies the following conditions: Carcinoma, Hepatocellular.

What interventions are being tested in trial NCT01666145?

The interventions under investigation include: Advanced Image Guidance (DEVICE).

Who is sponsoring clinical trial NCT01666145?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01666145 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carcinoma, Hepatocellular

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01666145's enrollment target sits among peer trials

14 25th of 27 higher than 2 of 27 other Carcinoma, Hepatocellular trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carcinoma, Hepatocellular trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01666145, the US trial registry maintained by the National Library of Medicine. NCT01666145 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.